Skip to content
Join our Newsletter

BIV on Global: U.S. pays US$375m for Vancouver-linked COVID drug; BBTV goes public, raises $172m

BIV reporter Tyler Orton discusses the U.S. government's plans to buy a COVID-19 therapeutic developed in part by Vancouver's AbCellera. Then, he dives into why BBTV went public amid the pandemic, raising $172 million in the process.

BIV reporter Tyler Orton discusses the U.S. government's plans to buy a COVID-19 therapeutic developed in part by Vancouver's AbCellera. Then, he dives into why BBTV went public amid the pandemic, raising $172 million in the process.